Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.
Read More…
Industry, Sector and Symbol
Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Phone800-334-8534
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.75 billion
Profitability
Miscellaneous
Employees9,500
Next Earnings Date3/2/2020 (Confirmed)
OptionableOptionable
Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions
What is Allscripts Healthcare Solutions' stock symbol?
Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."
How will Allscripts Healthcare Solutions' stock buyback program work?
Allscripts Healthcare Solutions declared that its Board of Directors has approved a share buyback program on Thursday, August 2nd 2018, which permits the company to buyback $250,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to buy up to 11.3% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board believes its shares are undervalued.
How were Allscripts Healthcare Solutions' earnings last quarter?
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) posted its earnings results on Monday, November, 4th. The software maker reported $0.17 earnings per share for the quarter, meeting the consensus estimate of $0.17. The software maker earned $445 million during the quarter, compared to analyst estimates of $450.04 million. Allscripts Healthcare Solutions had a return on equity of 5.98% and a net margin of 12.00%. The company's revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.18 EPS. View Allscripts Healthcare Solutions' Earnings History.
When is Allscripts Healthcare Solutions' next earnings date?
How can I listen to Allscripts Healthcare Solutions' earnings call?
Allscripts Healthcare Solutions will be holding an earnings conference call on Monday, March 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?
Allscripts Healthcare Solutions issued an update on its fourth quarter 2019
Pre-Market earnings guidance on Tuesday, January, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $450-455 million, compared to the consensus revenue estimate of $463.08 million.
What price target have analysts set for MDRX?
7 Wall Street analysts have issued 12 month price targets for Allscripts Healthcare Solutions' shares. Their forecasts range from $10.00 to $13.00. On average, they expect Allscripts Healthcare Solutions' share price to reach $11.71 in the next year. This suggests a possible upside of 34.2% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions.
What is the consensus analysts' recommendation for Allscripts Healthcare Solutions?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allscripts Healthcare Solutions.
What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?
Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:
- 1. According to Zacks Investment Research, "Allscripts ended the third quarter on a mixed note. The company continues to gain from the core Client Services unit, which displayed an improved performance in the quarter. Significant growth in third-quarter bookings also buoys optimism. The company continues to maintain momentum in its Provider business on the back of key client wins across solution set. The company is confident about its near and long-term outlook as it anticipates to benefit from a number of differentiated growth opportunities in both Provider and Veradigm businesses. However, the company witnessed a contraction in both gross and operating margins in the third quarter. It is also exposed to integration risks. Intense competition in the niche space is an added concern. Over the past year, Allscripts has underperformed its industry." (12/3/2019)
- 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on MDRX shares and maintain our price target at $10, After the market close on Thursday, May 2, MDRX reported 1Q19 results, with revenue slightly below our estimate. 1Q19 bookings increased 9% y/y. MDRX reiterated its 2019 guidance for non-GAAP EPS and bookings. The company continues its policy of not providing full year revenue guidance, but provided 2Q19 revenue guidance, which was below our estimate but in line with FactSet consensus. We note the company had previously provided a modest three-year CAGR outlook." (5/2/2019)
Has Allscripts Healthcare Solutions been receiving favorable news coverage?
News stories about MDRX stock have been trending very positive on Thursday, according to InfoTrie Sentiment. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Allscripts Healthcare Solutions earned a daily sentiment score of 4.0 on InfoTrie's scale. They also gave news headlines about the software maker a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Allscripts Healthcare Solutions.
Who are some of Allscripts Healthcare Solutions' key competitors?
What other stocks do shareholders of Allscripts Healthcare Solutions own?
Who are Allscripts Healthcare Solutions' key executives?
Allscripts Healthcare Solutions' management team includes the folowing people:
- Mr. Paul M. Black, CEO & Director (Age 61)
- Mr. Richard J. Poulton, Pres (Age 54)
- Mr. Dennis M. Olis, Chief Financial Officer (Age 56)
- Mr. Brian P. Farley, Exec. VP, Gen. Counsel, Corp. Sec. & Chief Admin. Officer (Age 49)
- Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 52)
Who are Allscripts Healthcare Solutions' major shareholders?
Allscripts Healthcare Solutions' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (3.20%), Tamarack Advisers LP (2.25%), Geode Capital Management LLC (1.75%), Jacobs Levy Equity Management Inc. (1.64%), Prudential Financial Inc. (1.52%) and Penn Capital Management Co. Inc. (1.08%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions.
Which institutional investors are selling Allscripts Healthcare Solutions stock?
MDRX stock was sold by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Fort Washington Investment Advisors Inc. OH, State Street Corp, Rothschild & Co. Asset Management US Inc., Royce & Associates LP, Adirondack Research & Management Inc., Penn Capital Management Co. Inc. and Principal Financial Group Inc.. View Insider Buying and Selling for Allscripts Healthcare Solutions.
Which institutional investors are buying Allscripts Healthcare Solutions stock?
MDRX stock was purchased by a variety of institutional investors in the last quarter, including Man Group plc, Jacobs Levy Equity Management Inc., Smith Graham & Co. Investment Advisors LP, California Public Employees Retirement System, Sculptor Capital LP, Cubist Systematic Strategies LLC, Knights of Columbus Asset Advisors LLC and Prudential Financial Inc.. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions.
How do I buy shares of Allscripts Healthcare Solutions?
Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Allscripts Healthcare Solutions' stock price today?
One share of MDRX stock can currently be purchased for approximately $8.73.
How big of a company is Allscripts Healthcare Solutions?
Allscripts Healthcare Solutions has a market capitalization of $1.42 billion and generates $1.75 billion in revenue each year. The software maker earns $412.33 million in net income (profit) each year or $0.55 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,500 workers across the globe.View Additional Information About Allscripts Healthcare Solutions.
What is Allscripts Healthcare Solutions' official website?
How can I contact Allscripts Healthcare Solutions?
Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]
MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
